Financial Spine Degenerative Disc Disease Treatment Market is Expected to Reach Revenue of USD 66.2 Bn by 2033, at 7.7% CAGR: Dimension Market Research byTim AllenOctober 8, 2024
Spine Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans byJosh SandbergAugust 21, 2024
Spine New4med GmbH Announces First Cases of its novel Basivertebral Nerve Ablation (BVNA) byTim AllenJuly 8, 2024
Spine Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain byTim AllenApril 25, 2024
Recon Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System byJosh SandbergApril 22, 2024
Recon Regulatory Top Stories Lipogems Announces First Patient Enrolled in the Second U.S. FDA IDE Study for the Treatment of Knee Osteoarthritis byTim AllenApril 8, 2024
Neuro Top Stories ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State byJosh SandbergMarch 5, 2024
Extremities Sports Medicine Top Stories Arthrex Launches Online Hub for Minimally Invasive Surgical Treatment Options With Nano Arthroscopy byJosh SandbergJanuary 15, 2024
Spine Top Stories Cresco Spine Announces Groundbreaking Spinal Connector Patent – A Leap Forward in Pediatric Spinal Treatment byJosh SandbergDecember 4, 2023
Financial Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain byJosh SandbergApril 20, 2023
